Objectives: Asthma is a heterogeneous disease with airway inflammation and has many phenotypes. There is a need for easily measurable biomarkers in the differentiation of phenotypes. Systemic immune-inflammation index (SII) has been studied in many malignancies and vasculitis as an important indicator of systemic inflammation and prognosis. The aim of this study is to test the usability of an easily calculated method like SII in the differentiation of asthma and NSAID-exacerbated respiratory disease (NERD).
